{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:42:31Z","timestamp":1791916951821,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"DOI":"10.7759\/cureus.78474","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:40:08Z","timestamp":1738665608000},"source":"Crossref","is-referenced-by-count":2,"title":["Long-Standing Untreated or Inadequately Treated Seropositive Rheumatoid Arthritis in the Golden Age of Disease-Modifying Antirheumatic Drugs"],"prefix":"10.7759","author":[{"given":"Cristine K","family":"Arcilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjit S","family":"Kaeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myint","family":"Thway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Principles of rheumatoid arthritis control","volume":"67","author":"Palferman TG","year":"2003","unstructured":"Palferman TG. Principles of rheumatoid arthritis control. J Rheumatol Suppl. 2003, 67:10-3.","journal-title":"J Rheumatol Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.64","article-title":"Mechanisms, impact and management of pain in rheumatoid arthritis","volume":"10","author":"Walsh DA","year":"2014","unstructured":"Walsh DA, McWilliams DF. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol. 2014, 10:581-92. 10.1038\/nrrheum.2014.64","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a brief overview of the treatment","volume":"27","author":"Bullock J","year":"2018","unstructured":"Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2018, 27:501-7. 10.1159\/000493390","journal-title":"Med Princ Pract"},{"key":"ref4","article-title":"Rheumatoid Arthritis","author":"Chauhan K","year":"2024","unstructured":"Chauhan K, Jandu JS, Brent LH, et al.. Rheumatoid Arthritis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.20230801.oo","article-title":"Overview of rheumatoid arthritis and scientific understanding of the disease","volume":"34","author":"Jahid M","year":"2023","unstructured":"Jahid M, Khan KU, Rehan-Ul-Haq, Ahmed RS. Overview of rheumatoid arthritis and scientific understanding of the disease. Mediterr J Rheumatol. 2023, 34:284-91. 10.31138\/mjr.20230801.oo","journal-title":"Mediterr J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051082","article-title":"Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment","volume":"13","author":"Wu D","year":"2022","unstructured":"Wu D, Luo Y, Li T, et al.. Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol. 2022, 13:1051082. 10.3389\/fimmu.2022.1051082","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9062008","article-title":"Systemic manifestations and complications in patients with rheumatoid arthritis","volume":"9","author":"Kim JW","year":"2020","unstructured":"Kim JW, Suh CH. Systemic manifestations and complications in patients with rheumatoid arthritis. J Clin Med. 2020, 9:2008. 10.3390\/jcm9062008","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks JA","year":"2019","unstructured":"Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019, 170:ITC1-16. 10.7326\/AITC201901010","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu AF","year":"2021","unstructured":"Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021, 10:2857. 10.3390\/cells10112857","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.05.007","article-title":"Extra-articular manifestations and complications of rheumatoid arthritis","volume":"21","author":"Young A","year":"2007","unstructured":"Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007, 21:907-27. 10.1016\/j.berh.2007.05.007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref11","article-title":"Rheumatoid arthritis: early diagnosis and treatment outcomes","volume":"2","author":"Heidari B","year":"2011","unstructured":"Heidari B. Rheumatoid arthritis: early diagnosis and treatment outcomes . Caspian J Intern Med. 2011, 2:161-70.","journal-title":"Caspian J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.41417","article-title":"Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift","volume":"73","author":"Deane KD","year":"2021","unstructured":"Deane KD, Holers VM. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol. 2021, 73:181-93. 10.1002\/art.41417","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes086","article-title":"Disease control with glucocorticoid therapy in rheumatoid arthritis","volume":"51 Suppl 4","author":"Bijlsma JW","year":"2012","unstructured":"Bijlsma JW. Disease control with glucocorticoid therapy in rheumatoid arthritis. Rheumatology (Oxford). 2012, 51 Suppl 4:iv9-13. 10.1093\/rheumatology\/kes086","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2023.2.2822","article-title":"Non-adherence to pharmacotherapy and its associated factors in outpatients with rheumatoid arthritis","volume":"21","author":"Jarab AS","year":"2023","unstructured":"Jarab AS, Abu Heshmeh SR, Al-Qerem WA, Mukattash TL, Beiram R, Aburuz S. Non-adherence to pharmacotherapy and its associated factors in outpatients with rheumatoid arthritis. Pharm Pract. 2023, 21:1-8. 10.18549\/PharmPract.2023.2.2822","journal-title":"Pharm Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.17169\/fqs-14.3.1932","article-title":"Noncompliance: a never-ending story. Understanding the perspective of patients with rheumatoid arthritis","volume":"14","author":"Stamer M","year":"2013","unstructured":"Stamer M, Schmacke N, Richter P. Noncompliance: a never-ending story. Understanding the perspective of patients with rheumatoid arthritis. Forum Qual Sozialforschung Forum Qual Soc Res. 2013, 14:1932. 10.17169\/fqs-14.3.1932","journal-title":"Forum Qual Sozialforschung Forum Qual Soc Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2018.25.1.47","article-title":"Prevalence and associated factors for non-adherence in patients with rheumatoid arthritis","volume":"25","author":"Kim D","year":"2018","unstructured":"Kim D, Choi JY, Cho SK, et al.. Prevalence and associated factors for non-adherence in patients with rheumatoid arthritis. J Rheum Dis. 2018, 25:47-57. 10.4078\/jrd.2018.25.1.47","journal-title":"J Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S282627","article-title":"Current and emerging DMARDs for the treatment of rheumatoid arthritis","volume":"13","author":"Mysler E","year":"2021","unstructured":"Mysler E, Caubet M, Lizarraga A. Current and emerging DMARDs for the treatment of rheumatoid arthritis. Open Access Rheumatol. 2021, 13:139-52. 10.2147\/OARRR.S282627","journal-title":"Open Access Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/252456","article-title":"Rheumatoid arthritis and the cervical spine: a review on the role of surgery","volume":"2015","author":"Gillick JL","year":"2015","unstructured":"Gillick JL, Wainwright J, Das K. Rheumatoid arthritis and the cervical spine: a review on the role of surgery. Int J Rheumatol. 2015, 2015:252456. 10.1155\/2015\/252456","journal-title":"Int J Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04579-1","article-title":"Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis","volume":"38","author":"Batko B","year":"2019","unstructured":"Batko B, Urba\u0144ski K, \u015awierkot J, et al.. Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis. Clin Rheumatol. 2019, 38:2473-81. 10.1007\/s10067-019-04579-1","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0643-0","article-title":"Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis","volume":"17","author":"Zhang T","year":"2015","unstructured":"Zhang T, Pope J. Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis. Arthritis Res Ther. 2015, 17:148. 10.1186\/s13075-015-0643-0","journal-title":"Arthritis Res Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2332406","article-title":"The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"56","author":"Wang HF","year":"2024","unstructured":"Wang HF, Wang YY, Li ZY, He PJ, Liu S, Li QS. The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Ann Med. 2024, 56:2332406. 10.1080\/07853890.2024.2332406","journal-title":"Ann Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment","volume":"6","author":"Huang S","year":"2020","unstructured":"Huang S, Kronzer VL, Dellaripa PF, et al.. Rheumatoid arthritis-associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol. 2020, 6:337-53. 10.1007\/s40674-020-00160-z","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People With Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson SR","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, et al.. 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People With Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024, 76:1201-13. 10.1002\/art.42860","journal-title":"Arthritis Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S24947","article-title":"Update on peripheral ulcerative keratitis","volume":"6","author":"Yagci A","year":"2012","unstructured":"Yagci A. Update on peripheral ulcerative keratitis. Clin Ophthalmol. 2012, 6:747-54. 10.2147\/OPTH.S24947","journal-title":"Clin Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/rai2.12022","article-title":"Tocilizumab in rheumatoid arthritis\u2010associated peripheral ulcerative keratitis: a 1\u2010year follow\u2010up case report","volume":"2","author":"Huang J","year":"2022","unstructured":"Huang J, Chen Z, Zhao L, et al.. Tocilizumab in rheumatoid arthritis\u2010associated peripheral ulcerative keratitis: a 1\u2010year follow\u2010up case report. Rheumatol Autoimmun. 2022, 2:45-50. 10.1002\/rai2.12022","journal-title":"Rheumatol Autoimmun"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04492-5","article-title":"ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography","volume":"40","author":"Grosse J","year":"2020","unstructured":"Grosse J, Allado E, Roux C, et al.. ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography. Rheumatol Int. 2020, 40:615-24. 10.1007\/s00296-019-04492-5","journal-title":"Rheumatol Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-861575","article-title":"Imaging of bone erosion in rheumatoid arthritis","volume":"8","author":"Guermazi A","year":"2004","unstructured":"Guermazi A, Taouli B, Lynch JA, Peterfy CG. Imaging of bone erosion in rheumatoid arthritis. Semin Musculoskelet Radiol. 2004, 8:269-85. 10.1055\/s-2004-861575","journal-title":"Semin Musculoskelet Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.04.001","article-title":"A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis","volume":"40","author":"Barsky AJ","year":"2010","unstructured":"Barsky AJ, Ahern DK, Orav EJ, et al.. A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis. Semin Arthritis Rheum. 2010, 40:222-32. 10.1016\/j.semarthrit.2010.04.001","journal-title":"Semin Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210953","article-title":"The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial","volume":"76","author":"Thomsen T","year":"2017","unstructured":"Thomsen T, Aadahl M, Beyer N, et al.. The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2017, 76:1603-6. 10.1136\/annrheumdis-2016-210953","journal-title":"Ann Rheum Dis"},{"key":"ref30","article-title":"Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials","author":"Knittle K","year":"2010","unstructured":"Knittle K, Maes S, De Gucht V. Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials. Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews. Centre for Reviews and Dissemination (UK), York, UK; 2010."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314085-long-standing-untreated-or-inadequately-treated-seropositive-rheumatoid-arthritis-in-the-golden-age-of-disease-modifying-antirheumatic-drugs","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:40:10Z","timestamp":1738665610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314085-long-standing-untreated-or-inadequately-treated-seropositive-rheumatoid-arthritis-in-the-golden-age-of-disease-modifying-antirheumatic-drugs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.78474","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,4]]}}}